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Abstract
Introduction
HIV causes defects in memory B cells in children, but the mechanisms of those defects
have not been fully elucidated. One possible mechanism is the lack of T-cell help to B cells
during immune reactions. However, few studies have assessed the effect of HIV on follicular
helper T cells (TFH cells) in children.
Methods
In this study, follicular-homing CD4 T cells and memory B cells were assessed in HIV-infected
children and compared with children from the community. CXCR5 and CD45RO were used
as markers of follicular-homing T cells and memory T cells, respectively. Memory TFH cells
were identified as CD3+CD8-CD4+CXCR5+CD45RO+PD1+. Central memory T cells were
identified based on CCR7 expression. Relationship between the proportions of follicular-hom-
ing CD4 T cells and memory B cells were determined in multivariable regression models.
Results
Highly viremic HIV-infected children had lower proportions of memory TFH cells when com-
pared with community control children. In multivariable analyses, high proportions of mem-
ory TFH cells were associated with increased percentages of resting memory B cells after
adjusting for other covariates.
Conclusion
The impact of HIV on follicular helper T cells could influence the accumulation of memory B
cells in HIV-infected children.
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Introduction
Even though depletion of CD4 T cells is the hallmark of HIV-induced immune dysfunction,
the virus causes many other immunological abnormalities within the CD4 T-cell compart-
ment. CD4 T cells from HIV patients are qualitatively defective, displaying features of aberrant
immune activation as depicted by high levels of markers of activation [1]. Paradoxically, they
also have impaired responsiveness to stimuli, an observation that has been attributed to the
lymphocyte exhaustion that is characterized by up-regulation of inhibitory molecules [2, 3].
HIV is also associated with skewing of the subset-distribution of CD4 T cells. Viremic patients
have fewer IL-2 producing central memory CD4 T cells [4]. In addition, active HIV viremia is
associated with increased frequencies of follicular helper T cells (TFH cells) in lymphoid tissues,
suggesting increased TFH activity [5].
HIV patients also make poor antibody and memory B-cell responses to routine vaccines
and common infections [6–14]. The poor memory B-cell responses leave the patients, espe-
cially children, prone to repeated infections despite previous exposures and/or immunizations.
Considering that one of the major functions of CD4 T cells is to provide help to B cells, the
HIV-induced B-cell defects could be due to either depletion of CD4 T cells or HIV-induced
qualitative defects in the CD4 T cells. Investigating the effect of HIV on TFH cells, the subset of
CD4 T cells that provides help to B cells in germinal centres, is necessary to comprehensively
understand the mechanisms by which HIV impairs B-cell responses. Indeed, TFH cells from
the lymphoid tissues of HIV patients have been shown to be poor at helping the patients’ B
cells in vitro, an effect that has been attributed to increased PD1-PDL1 interaction [15].
Unfortunately, access to lymphoid tissues, the anatomical location of TFH cells, entails per-
forming invasive procedures and is logistically complicated. Attempts have therefore been
made to identify counterparts of TFH cells in peripheral circulation. Morita et al identified cir-
culating TFH on the basis of their CXCR5 expression, the marker for follicular homing, and
showed that Th2 and Th17 skewing within this subset was associated with active disease in
juvenile dermatomyositis [16]. Similarly, Pallikkuth et al used CXCR5 to identify circulating
TFH cells and associated their expansion with the magnitude of antibody response against the
2009 H1N1/09 vaccine in HIV patients [17]. Locci et al and Cohen et al described them as
CXCR5+CXCR3-PD1+ and CXCR5+PD1+, respectively, and observed an association with
eventual development of HIV cross-reactive antibodies [18, 19]. Boswell et al reported that the
best B-cell helper capabilities were in the CXCR5highCCR6highPD1high subset of CD4 T cells,
though their frequencies did not correlate with development of cross-reactive neutralizing
antibodies [20]. More recently, Schultz et al suggested that IL-21 secretion was the best marker
for circulating memory TFH cells [21].
In this study on HIV-infected children, the proportions of circulating TFH cells and other
follicular-homing CD4 T cells, and their relationship with memory B cells, were assessed. Con-
sidering that most previous studies in HIV used CXCR5 and PD1 to identify circulating TFH
cells, the same markers were used here.
Materials and methods
Study population
HIV-infected children aged 18 months to 10 years were recruited from the Comprehensive
Care and Research Clinic at Kilifi County Hospital in 2012. The children were treated in accor-
dance to the WHO guidelines at the time; those younger than 24 months were put on HAART
regardless of their immunological and clinical profile, those between 25 months and 59
months were put on HAART if their CD4 percentages were below 25% or if they were in
Follicular helper T cells in pediatric HIV
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WHO clinical stages 3 or 4 whereas children above 60 months of age were put on HAART if
their CD4 percentages were below 20% or if they were in WHO clinical stages 3 or 4 [22].
Some children were recruited when it was their first time in the clinic (i.e. newly enrolled).
The other children were recruited if they had received co-trimoxazole prophylaxis alone or in
combination with HAART for at least six months. Viral loads were determined at the Inter-
national Centre for Reproductive Health in Mombasa using a RT-qPCR test from Agence
Nationale de Recherches sur le SIDA with a detection limit of 300 RNA copies/ml [23].
Community control children were recruited from the same community. They did not have
fever, malaria parasitemia or any other active infection at the time of collecting the blood.
Due to ethical constraints, the community control children were not directly assessed for
HIV infection. However, the HIV prevalence among women in the coastal region was 6.1%,
and, due to Prevention of Mother To Child Transmission (PMTCT) programs, the HIV
prevalence was less than 1% among children in the community [24]. Written informed con-
sent was obtained from the parents or guardians of all children. The study protocol was
reviewed and approved by Kenya National Ethical Review Committee of Kenya Medical
Research Institute (SSC numbers 1633 and 1131).
T-cell and B-cell subset determination in PBMCs by flow cytometry
A total of five milliliters of blood were obtained from each child. Plasma and the cellular frac-
tions were separated by centrifugation. Peripheral blood mononuclear cells (PBMCs) were iso-
lated from the cellular fraction by gradient centrifugation and stored in liquid nitrogen at 5
million PBMCs/ml in new born bovine serum containing 10% DMSO. On the day of the
assay, PBMCs were thawed and washed in RPMI media containing 10% new born bovine
serum, 100 units/ml penicillin, 0.1 mg/ml Streptomycin, 2 mM L-glutamine and 10 mM
Hepes buffer.
The following antibodies were used: anti-IgD PE (IADB6), anti-CD19 ECD (J3-119), anti-
CD3 ECD (UCHT1) and anti-CD27 PE-Cy5 (1A4CD27) from Beckman Coulter; anti-CD38-
PE-Cy7 (HIT2) from eBiosciences; anti-CD8 FITC (DK25) from DAKO; anti-CXCR5 Brilliant
Violet 421 (RF8B2), anti-CD4 PE-Cy7 (SK3), anti-CD21 APC (B-ly4) and anti-CD27 Brilliant
Violet 421(M-T271) from BD Biosciences; anti-CCR7 APC (G043H7), anti-CD45RO APC-
Cy7 (UCHL1) and anti-CD10 PE-Cy5 (HI10a) from Biolegend.
PBMCs were stained with various cocktails of the surface markers. At least 80,000 events
were acquired on a nine-colour Cyan ADP flow cytometer (Beckman Coulter). Analyses and
determination of different subsets were done in FlowJo software version 10 (TreeStar inc,
Flowjo Africa Scheme).
Total follicular-homing CD4 T cells were identified based on the expression of CXCR5 i.e.
CD3+CD8-CD4+CXCR5+. Since circulating follicular helper cells are expected to be antigen-
experienced, the proportions of memory follicular-homing CD4 T cells were also determined
based on the additional expression of CD45RO, the marker of memory in T cells i.e. CD3+
CD8-CD4+CXCR5+CD45RO+. Since some studies have shown that the B-cell helper capabili-
ties are enriched in the PD1+CXCR5+ memory CD4 T cells, the proportions of CD3+CD8-
CD4+CXCR5+CD45RO+PD1+ were also determined, here referred as memory follicular helper
CD4 T cells (memory TFH cells). Within the memory compartments, central memory CD4 T
cells were determined as CCR7+ cells, whereas effector memory CD4 T cells were determined
as CCR7- cells.
Total resting memory B cells were identified as CD19+CD27+CD21+CD10-CD38-/+ as
described in previous studies [13, 25]. Further analyses were done to identify IgD+ (unswitched)
and IgD- (switched) resting memory B cells.
Follicular helper T cells in pediatric HIV
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Statistical analyses
Active HIV viremia has been previously associated with B-cell defects [9, 13, 14, 26]. Therefore,
the HIV-infected children were stratified into high viremia and low viremia groups based on a
cut off of 5000 copies/ml, similar to our previous study and the WHO definition of treatment
failure as at the time of enrollment of the children [13, 22].
Comparisons between different groups of children were done using the Mann-Whitney test
(Wilcoxon rank sum test). Correlations were done using Spearman’s rank-order correlation.
Multivariable quantile regression analyses were done to assess independent relationships
between various parameters. P values were considered significant if they were less than 0.05.
STATA version 13 (STATA corporation) was used for all analyses.
Results
Characteristics of the study population
The population characteristics of the participants are shown in Table 1. A total of 52 children
were recruited into the study of whom 36 were HIV-infected and 16 were community control
children. Of the HIV-infected children, 15 had high viremia. Median viral loads were 4.6
(IQR, 4.3–5.0) log10RNA copies/ml in the high viremia group and 1.9 (IQR, 0.0–3.1) log10RNA
copies/ml in the low viremia group (P<0.01). Nine of the high viremia children and 20 of the
low viremia children were on HAART (P<0.01). CD4 T percentages data were available for 28
of the 36 HIV-infected children. Full blood counts data were available for 32 of the 36 HIV-
infected children and all 16 community controls. The high viremia group had fewer mono-
cytes when compared with the community controls (median 0.40 [IQR, 0.29–0.53] x 103 cells/
μL versus median 0.49 [IQR, 0.41–0.60] x 103 cells/μL, P = 0.04). Interestingly, the low viremia
group had fewer eosinophils when compared with both high viremia group (median 0.19
[IQR, 0.11–0.34] x 103 cells/μL versus median 0.53 [IQR, 0.15–1.02] x 103 cells/μL, P = 0.01)
and community controls (median 0.19 [IQR, 0.11–0.34] x 103 cells/μL versus median 0.49
[IQR, 0.30–0.68] x 103 cells/μL, P<0.01). The high viremia group had lower hemoglobin levels
Table 1. Characteristics of the study population.
High viremia (HV) Low viremia (LV) Community controls (CC) Normal range P value
HV vs LV HVvs CC LV vs CC
N 15 21 16 N/A
Age (years) 5.9 (3.8–6.9) 5.3 (2.6–8.0) 5.8 (5.0–6.6) N/A 0.96 0.75 0.69
% CD4+ T cells 22.0 (16.7–34.4) 30.0 (20.7–36.2) N/D 0.31 N/A N/A
HIV log10 RNA copies/ml 4.6 (4.3–5.0) 1.9 (0.0–3.1) N/A N/A <0.01 N/A N/A
% on HAART (n) 60% (9) 95% (20) N/A N/A <0.01 N/A N/A
Lymphocytes (x 103/μL) 3.8 (2.3–4.2) 3.6 (3.1–4.5) 3.4 (3.1–3.9) 1.7–7.6 0.65 0.63 0.43
Monocytes (x 103/μL) 0.40 (0.29–0.53) 0.52 (0.34–0.66) 0.49 (0.41–0.60) 0.3–1.5 0.22 0.04 0.83
Neutrophils (x 103/μL) 2.0 (1.3–2.5) 2.6 (1.6–3.9) 2.3 (2.1–3.6) 1.2–5.5 0.23 0.13 0.79
Eosinophils (x 103/μL) 0.53 (0.15–1.02) 0.19 (0.11–0.34) 0.49 (0.30–0.68) 0.1–1.3 0.01 0.93 <0.01
Platelets (x 103/μL) 349 (293–449) 365 (292–459) 370 (278–444) 159–564 0.98 0.93 0.76
Hemoglobin (g/dL) 10 (9–11) 11 (10–11) 11 (11–12) 8.2–12.7 0.15 0.02 0.11
Values shown for age, % CD4+ T cells, HIV log10 RNA copies/ml, lymphocytes, monocytes, neutrophils, eosinophils, platelets and hemoglobin are medians
and interquartile ranges. Values under the normal range column refer to predetermined hematology reference values of normal children in Kilifi county. %
CD4+ T cells refer to frequencies of CD4 T cells as percentage of total lymphocytes. Statistical tests used: Wilcoxon rank sum test was used for age, % CD4
+ T cells, HIV log10 RNA copies/ml, lymphocytes, monocytes, neutrophils, eosinophils, platelets and hemoglobin. Chi-squared test was used for % on
HAART. N/D—Not determined. N/A—Not applicable.
https://doi.org/10.1371/journal.pone.0175570.t001
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when compared with community controls (median 10 [IQR, 9–11] g/dL versus median 11
[IQR, 11–12] g/dL, P = 0.02).
HIV-infected children have reduced proportions of circulating follicular-
homing CD4 T cells
Median proportions of total follicular-homing CD4 T cells (CD3+CD8-CD4+CXCR5+), mem-
ory follicular-homing CD4 T cells (CD3+CD8-CD4+CXCR5+CD45RO+) and memory TFH
cells (CD3+CD8-CD4+CXCR5+CD45RO+PD1+) were lower in both HIV-infected groups
when compared with community controls, except for memory TFH cells in the low viremia
group (Fig 1A–1C). The high viremia group also had significantly lower frequencies of central
memory follicular-homing CD4 T cells and central memory TFH cells when compared with
the low viremia and community control groups (Fig 1D and 1F). In addition, the two HIV-
infected groups had lower frequencies of effector memory follicular-homing CD4 T cells when
compared with the community controls group (Fig 1E). In the memory TFH compartment, the
high viremia group, but not the low viremia group, had lower frequencies of effector memory
TFH cells when compared with the community controls group (Fig 1G).
Among all HIV-infected children, there was a direct correlation between total CD4 percent-
ages and total follicular-homing CD4 T cells. A similar but non-significant trend was observed
between total CD4 percentages and memory follicular-homing CD4 T cells (P = 0.06) but not
memory TFH cells (Fig 2A–2C). We also observed a trend towards direct correlation between
total CD4 percentages and effector memory follicular-homing CD4 T cells (P = 0.09), but no
relationship with other memory follicular-homing subsets (Fig 2D–2G).
Low proportions of memory TFH cells are independent predictors of
reduced proportions of resting memory B cells in HIV-infected children
To assess the relationship between memory follicular-homing CD4 T cells and memory B
cells, the proportions of resting memory B cells were determined in accordance to previous
Fig 1. HIV infection is associated with low proportions of circulating follicular helper T cells (TFH cells).
Proportions of (A) total follicular-homing CD4 T cells (CXCR5+CD4+), (B) memory follicular-homing CD4
T cells (CXCR5+CD45RO+CD4+), (C) memory TFH cells (CXCR5+CD45RO+PD1+CD4+), (D) central memory
follicular-homing CD4 T cells (CXCR5+CD45RO+CCR7+CD4+), (E) effector memory follicular-homing CD4 T
cells (CXCR5+CD45RO+CCR7-CD4+), (F) central memory TFH cells (CXCR5+CD45RO+PD1+CCR7+CD4+)
and (G) effector memory TFH cells (CXCR5+CD45RO+PD1+CCR7-CD4+) as percentages of total CD4 T cells.
Each symbol represents a child. High viremia,5000 RNA copies/ml; Low viremia, <5000 RNA copies/ml.
Horizontal lines and error bars represent median, 25th and 75th percentiles. Red symbols represent HIV-
infected children who were not on HAART. Blue symbols represent HAART-treated children. Statistical test:
Wilcoxon’s rank sum test.
https://doi.org/10.1371/journal.pone.0175570.g001
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studies [13, 14, 25]. Similar to the previous reports, when compared with community controls,
both high viremia and low viremia groups had lower proportions of total resting memory B
cells (P<0.01 in both cases), IgD+ (Unswitched) resting memory B cells (P<0.01 and P = 0.01,
respectively) and IgD- (switched) resting memory B cells (P<0.01 and P = 0.01, respectively)
(Fig 3A–3C) [9, 11, 13, 14, 27].
Some reports have suggested that CXCR5+PD1+ memory CD4 T cells are the main predic-
tors of B-cell function with regard to the development of broadly neutralizing antibodies in
HIV patients [18, 19]. Therefore, the association between memory TFH cells (CD3
+CD8-CD4+
CXCR5+CD45RO+PD1+) and resting memory B cells was assessed in multivariable quantile
regression analyses. When the independent predictions of resting memory B-cell subsets by
HIV infection, age, memory TFH cells, high viremia, interaction of age with high viremia and
HAART were assessed, lower proportions of memory TFH cells were predictors of lower pro-
portions of total and IgD- resting memory B cells. Being older was a predictor of higher pro-
portions of IgD- resting memory B cells (Table 2). The covariates HIV infection, age, high
viremia, interaction of age with high viremia and HAART had been identified in a previous
larger study [13].
Fig 2. In the HIV-infected cohort, proportions of total follicular-homing CD4 T cells are directly
correlated with CD4 percentages. Correlation analyses between CD4 T cells (as percentage of total
lymphocytes) and: (A) total follicular-homing CD4 T cells (CXCR5+CD4+), (B) memory follicular-homing CD4
T cells (CXCR5+CD45RO+CD4+), (C) memory TFH cells (CXCR5+CD45RO+PD1+CD4+), (D) central memory
follicular-homing CD4 T cells (CXCR5+CD45RO+CCR7+CD4+), (E) effector memory follicular-homing CD4 T
cells (CXCR5+CD45RO+CCR7-CD4+), (F) central memory TFH cells (CXCR5+CD45RO+PD1+CCR7+CD4+)
and (G) effector memory TFH cells (CXCR5+CD45RO+PD1+CCR7-CD4+). Circles represent highly viremic
children and squares represent lowly viremic children. Red symbols represent HAART-naïve children and
blue symbols represent HAART-treated children. Statistical test: Spearman’s rank-order correlation.
https://doi.org/10.1371/journal.pone.0175570.g002
Fig 3. HIV-infected children have reduced proportions of resting memory B cells. Proportions of (A)
total resting memory B cells, (B) IgD+ resting memory B cells and (C) IgD- resting memory B cells as
percentages of total B cells. Each symbol represents a child. High viremia,5000 RNA copies/ml; Low
viremia, <5000 RNA copies/ml. Horizontal lines and error bars represent median, 25th and 75th percentiles.
Red symbols represent HIV-infected children who were not on HAART. Blue symbols represent HAART-
treated children. Statistical test: Wilcoxon’s rank sum test.
https://doi.org/10.1371/journal.pone.0175570.g003
Follicular helper T cells in pediatric HIV
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In additional analyses on the predictive ability of other subsets within the follicular-homing
CD4 T cells compartment, lower proportions of total follicular-homing CD4 T cells were pre-
dictors for lower proportions of total and IgD+ resting memory B cells (P<0.01 and P = 0.02,
respectively). Similarly, low proportions of memory follicular-homing CD4 T cells were pre-
dictors for lower proportions of total and IgD+ resting memory B cells (P<0.01 and P = 0.02,
respectively). Low proportions of central memory follicular-homing CD4 T cells were predic-
tors for low proportions of total and IgD- resting memory B cells (P<0.01 and P = 0.03, respec-
tively) whereas low proportions of effector memory follicular-homing CD4 T cells were
predictors for low proportions of total and IgD+ resting memory B cells (P = 0.02 and P<0.01,
respectively). Low proportions of central memory TFH cells were predictors for low propor-
tions of total and IgD- resting memory B cells (P = 0.02 in both cases) whereas low proportions
of effector memory TFH cells were predictors for low proportions of total and IgD
+ resting
memory B cells (P<0.01 in both cases) (Data not shown).
Discussion
Since antibodies have proven to play a critical role in vaccine mediated immunity against
many infections, it would be important to understand the factors that determine the magni-
tude and quality of B-cell responses. Defects in the B-cell compartment leave HIV patients
exposed to many opportunistic infections that would otherwise be controlled by a normal
Table 2. Estimated change (beta coefficients) in frequencies of memory B-cell subsets with variations
in age, HIV status, proportions of memory TFH cells, viremia and HAART in multivariable regression.
Beta Coefficient
(Standard Error)
P value
Total resting memory
Age (Years) 0.3 (0.3) 0.30
HIV infection -3.9 (2.2) 0.08
Memory TFH cells 3.2 (1.1) <0.01
High viremia -1.1 (3.0) 0.72
Age*high viremia 0.0 (0.5) 0.96
HAART 0.6 (1.9) 0.76
IgD+ resting memory
Age (Years) -0.1 (0.1) 0.46
HIV infection -1.4 (1.1) 0.22
Memory TFH cells 0.9 (0.5) 0.13
High viremia -1.9 (1.6) 0.23
Age*high viremia 0.3 (0.3) 0.27
HAART 0.4 (1.0) 0.68
IgD- resting memory
Age (Years) 0.5 (0.2) 0.02
HIV infection -2.0 (1.5) 0.20
Memory TFH cells 2.0 (0.7) 0.01
High viremia 0.8 (2.1) 0.71
Age*high viremia -0.3 (0.3) 0.39
HAART 0.2 (1.3) 0.89
Each memory B-cell subset was independently predicted in a quantile regression model incorporating the
reported variables. Age*high viremia is an interaction term for age and level of viremia. P values <0.05 were
considered significant. Significant results are in bold text.
https://doi.org/10.1371/journal.pone.0175570.t002
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antibody response [6, 7, 10, 12]. This problem is particularly significant in HIV-infected chil-
dren, whose immature immune system develops in a background of HIV infection, leading to
faster disease progression and probably more severe defects [28, 29]. Understanding the mech-
anisms by which HIV causes B-cell defects could inform interventions to improve antibody
responses in HIV-infected children.
TFH cells are the distinct CD4 T cell subset that provides help to B cells inside B-cell follicles
in lymphoid tissues [30]. The recent identification of memory circulating counterparts of TFH
cells in blood has enabled studies that evaluate how HIV-induced defects on the TFH compart-
ment affect B-cell responses [17–19, 27].
In the current study, we show that the proportions of circulating follicular-homing CD4 T
cells are lower in HIV-infected children when compared to community control children, simi-
lar to a previous report [27]. HIV preferentially replicates in TFH cells in lymphoid tissues,
probably leading to their preferential destruction, a phenomenon that could spill over into the
circulating memory TFH cells compartment [31]. Furthermore, B cells play a major role in
reciprocally maintaining TFH cells via co-stimulatory signals, and the detrimental effect of HIV
on the B-cell compartment could indirectly impact the TFH compartment [15]. Increased
numbers of TFH cells have been observed in lymphoid tissues of HIV patients, suggesting that
depletion in peripheral blood could alternatively be due to, at least in part, increased trafficking
into lymphoid organs [5, 32].
Notably, low proportions of memory TFH cells in HIV-infected children were associated
with reduced proportions of total and IgD- (class-switched) resting memory B cells in multi-
variable analyses after adjusting for other covariates. Previous reports have shown a similar
link between frequencies of circulating memory TFH cells and the quality of B-cell responses
[17–19, 27]. TFH cells in lymphoid tissues are important for the formation of germinal centers,
the histological sites where long-lived plasma cells and memory B cells are generated during
immune reactions. They also provide important contact and soluble signals that drive B-cell
affinity maturation and class switch recombination, processes that determine the quality of the
B-cell response [30]. The observed paucity of circulating memory TFH cells implies that HIV-
infected children have impaired TFH activity resulting into the observed impaired generation
of memory B cells. The reduced B-cell helper activity could be exacerbated by other qualitative
defects in addition to these quantitative defects. For instance, memory TFH cells from HIV-
infected children could have altered differentiation patterns into less functional effector phe-
notypes. In this study, viremic HIV-infected children had fewer proportions of both central
and effector memory TFH cells, suggesting that the paucity of central memory TFH cells was
not due to differentiation into effector memory TFH cells. However, TFH cells from HIV-
infected children have previously been shown to be defective at secreting IL-4, a cytokine that
constitutes T-cell help to B cells and is required for maintenance of germinal centers, thus
influencing the development of memory B cells [27, 30]. It is not known if the expression of
surface molecules that mediate T-cell to B-cell interactions is altered in various subsets of fol-
licular-homing CD4 T cells in HIV-infected children. Additional studies are required to assess
such possibilities. Of note, the observed relationship between memory TFH cells and memory
B cells does not rule out the possibility of direct inhibition of B-cell responses by virion factors
as suggested by some studies [33, 34].
Notably, the low viremia children also had reduced proportions of some of the subsets within
follicular-homing CD4 T-cell compartment when compared with community controls. This
observation implies that controlling viremia does not fully restore the memory TFH compart-
ment and that the HAART-treated children would need to rebuild the memory TFH compart-
ment through re-exposures to the various antigens. As such, re-immunization programmes
could be beneficial to HAART-treated HIV-infected children.
Follicular helper T cells in pediatric HIV
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Due to sample limitation, our study could not assess antigen-specific responses. It would be
interesting to determine if similar results will be obtained with regard to antigen-specific
memory TFH cells and antigen specific B cells in HIV-infected children, and whether such
responses predict the quality of antibody responses upon revaccination. Nevertheless, the data
suggest that designing interventions that modulate TFH cells could lead to better B-cell
responses in HIV-infected children.
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